The GI-MAP (Gastrointestinal Microbial Assay Plus) is an advanced stool analysis test that provides an in-depth look at your gut microbiome
For best preservation, many peptides should be stored at 4C or colder and kept away from bright light
AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram
Recalls & Warnings June 11, 2015 FDA Warns Maker of Fruit Energy Drinks for Drug Claims On May 19, 2015, the FDA issued a warning letter to CK Management, Inc

The Big Picture: Where Tirzepatide Fits Among Weight Loss Medications Today there are six FDA-approved medications most commonly prescribed for chronic weight management: Tirzepatide (brand name Zepbound) weekly injection, FDA-approved for weight management in November 20234 Semaglutide (brand names Wegovy and Ozempic) weekly injection Liraglutide (brand name Saxenda) daily injection Phentermine (often combined with topiramate as Qsymia) daily oral pill Naltrexone-bupropion (brand name Contrave) daily oral pill Orlistat (brand names Xenical and Alli) oral capsule with meals In large clinical trials, the average percent body weight lost over 1218 months looks roughly like this:[1][1] Tirzepatide: about 20% Semaglutide: about 14% Phentermine/topiramate: about 9% Liraglutide: about 5% Naltrexone-bupropion: about 5% Orlistat: about 3% Tirzepatide is, on paper, the most effective
A 60-second self-check Ask yourself a few simple questions and write the answers down